Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Genetic Lingo01:11

Genetic Lingo

Overview
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synergistic Role of <i>Streptomyces</i> Composite Inoculants in Mitigating Wheat Drought Stress Under Field Conditions.

Plants (Basel, Switzerland)·2025
Same author

Extracellular Vesicles and Glaucoma: Opportunities and Challenges.

Current eye research·2025
Same author

Microbiota-derived succinate promotes enterohaemorrhagic Escherichia coli virulence via lysine succinylation.

Nature microbiology·2025
Same author

Sexual dimorphism in the downregulation of extracellular matrix genes contributes to aortic stiffness in female mice.

American journal of physiology. Heart and circulatory physiology·2025
Same author

Efficacy of immune checkpoint inhibitors in the treatment of soft tissue sarcoma: A systematic review and meta-analysis of clinical trials.

International immunopharmacology·2025
Same author

Two-component system GrpP/GrpQ promotes pathogenicity of uropathogenic Escherichia coli CFT073 by upregulating type 1 fimbria.

Nature communications·2025
Same journal

Three-Dimensional Platform-Dependent Modulation of Stemness and EMT-Associated Gene Expression in Primary and Metastatic Uveal Melanoma Models.

Experimental eye research·2026
Same journal

Early Proteomic and Metabolic Signatures of Liver and Eye in OAT-Deficient Mice.

Experimental eye research·2026
Same journal

Inhibition of STAT6 signaling by rebamipide attenuates IL-4- and IL-13-induced eotaxin expression in corneal fibroblasts.

Experimental eye research·2026
Same journal

Translational animal model for genetic predisposition to anophthalmia/microphthalmia.

Experimental eye research·2026
Same journal

Inhibitory effect of the water-soluble retinoid X receptor partial agonist CAt-PMN on allergic conjunctivitis-like responses in mice.

Experimental eye research·2026
Same journal

Rheology of tear lipid components and their influence on surface properties.

Experimental eye research·2026
See all related articles

Related Experiment Video

Updated: May 29, 2026

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

Molecular genetics in glaucoma.

Yutao Liu1, R Rand Allingham

  • 1Center for Human Genetics, Duke University Medical Center, Durham, NC, USA.

Experimental Eye Research
|August 30, 2011
PubMed
Summary
This summary is machine-generated.

This review explores genetic factors in primary open-angle glaucoma (POAG), angle-closure glaucoma (ACG), and exfoliation glaucoma (XFG). It examines genetic investigations across various glaucoma types, including rare forms.

More Related Videos

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma
12:48

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma

Published on: May 11, 2015

Related Experiment Videos

Last Updated: May 29, 2026

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma
12:48

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma

Published on: May 11, 2015

Area of Science:

  • Ophthalmology
  • Genetics
  • Medical Research

Background:

  • Glaucoma involves progressive loss of retinal ganglion cells, leading to optic neuropathy and vision loss.
  • Primary open-angle glaucoma (POAG), chronic angle-closure glaucoma (ACG), and exfoliation glaucoma (XFG) are leading causes of global blindness.
  • Both genetic and environmental factors influence glaucoma development.

Purpose of the Study:

  • To review the current genetic investigations of prevalent glaucoma forms (POAG, ACG, XFG).
  • To examine genetic research in less common glaucomas, including primary congenital glaucoma (PCG) and developmental glaucomas.
  • To consolidate knowledge on the genetic underpinnings of diverse glaucoma phenotypes.

Main Methods:

  • Literature review of genetic studies on glaucoma.
  • Analysis of research on POAG, ACG, XFG, PCG, developmental glaucomas, and pigment dispersion glaucoma.
  • Synthesis of findings regarding genetic factors and glaucoma phenotypes.

Main Results:

  • Identified key genetic factors contributing to POAG, ACG, and XFG.
  • Highlighted genetic associations in rarer forms of glaucoma.
  • Provided an overview of the current genetic landscape of glaucoma.

Conclusions:

  • Genetic investigations are crucial for understanding glaucoma's complex etiology.
  • Further research into genetic factors can inform diagnosis and treatment strategies.
  • Understanding genetic contributions is vital for combating glaucoma-related vision loss.